Drug Type Synthetic peptide |
Synonyms LK-409, LK409 |
Target |
Action stimulants |
Mechanism CAMP stimulants(Cathelicidin antimicrobial peptide stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H27N3O6 |
InChIKeyYRUZBSMLFFKORY-NWDGAFQWSA-N |
CAS Registry142489-43-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immunologic Deficiency Syndromes | Preclinical | United States | - | - |
Immunologic Deficiency Syndromes | Preclinical | Japan | - | - |
Immunologic Deficiency Syndromes | Preclinical | Slovenia | - | |
Immunologic Deficiency Syndromes | Preclinical | Slovenia | - | |
Neoplasms | Preclinical | Slovenia | - | |
Neoplasms | Preclinical | Slovenia | - |